1Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449
2Undas A,Brummel KE,Musial J,et al.Simvastatin depresses blood clotting by inhibiting activation of prothrombin,factor V,and factor XIII and by enhancing factor Va inactivation[J].Circulation,2001,103(18):2248-2253
3Werner N,Priller J,Laufs U,et al.Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation:effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition[J].Arterioscler Thromb Vasc Biol,2002,22(10):1567-15
4Li D,Chen H,Romeo F,et al.Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1[J].J Pharmacol Exp Ther,2002,302(2):601-5
5Silva EP,Fonseca FA,Ihara SS,et al.Early benefits of pravastatin to experimentally induced atherosclerosis[J].J Cardiovasc Pharmacol,2002,39(3):389-395
6Wassman S,Faul A,Hennen B,et al.Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function[J].Circ Res,2003,93(9):e98-e103
7Tsunekawa T,Hayashi T,Kano H,et al.Cerivastatin,a hydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabetic patients within 3 days [J].Circulation,2001,104(4):376-379
8Laufs U,Gertz K,Dirnagl U,et al.Rosuvastatin,a new HMG-CoA reductase inhibitor,upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice[J].Brain Res,2002,942(1-2):23-30
9Vasa M,Fichtlscherer S,Adler K,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001,103(24):2885-2890
10Bellosta S,Ferri N,Arnaboldi L,et al.Pleiotropic effects of statins in atherosclerosis and diabetes[J].Diabetes Care,2000,23 Suppl 2:B72-B78
